To the full analysis
Buyback calculator for UroGen Pharma
UroGen Pharma stock: key metrics
URGNUroGen Pharma had an operating margin of −113.7% and a return on invested capital (ROIC) of −50.1% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2013 | no data | no data | no data |
| 2014 | no data | no data | no data |
| 2015 | no data | no data | no data |
| 2016 | 99.8% | 4.6% | −11.1% |
| 2017 | 92.6% | −244.5% | −245.2% |
| 2018 | −59.8% | −6,842.2% | −6,707.2% |
| 2019 | 100.0% | −608,211.1% | −584,144.4% |
| 2020 | 91.4% | −1,074.2% | −1,088.9% |
| 2021 | 89.3% | −192.1% | −230.7% |
| 2022 | 88.1% | −122.8% | −170.6% |
| 2023 | 88.7% | −79.2% | −123.6% |
| 2024 | 90.2% | −107.1% | −140.4% |
| 2025 | 88.7% | −113.7% | −139.8% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2013 | −100.0% | −97.7% | −100.0% |
| 2014 | −100.0% | no data | −100.0% |
| 2015 | −74.0% | −95.1% | −65.4% |
| 2016 | −11.9% | 3.4% | −8.4% |
| 2017 | −29.2% | −35.6% | −26.5% |
| 2018 | −84.0% | −76.9% | −73.1% |
| 2019 | −58.3% | −63.4% | −52.0% |
| 2020 | −100.0% | −70.6% | −100.0% |
| 2021 | −100.0% | −73.7% | −92.5% |
| 2022 | 122.9% | −59.7% | −80.9% |
| 2023 | 156.8% | −40.0% | −57.3% |
| 2024 | 200.0% | −39.5% | −44.4% |
| 2025 | 145.5% | −50.1% | −76.6% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 May 2018)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.